Atherosclerosis seems not to be associated with hyperinsulinaemia in patients with familial hypercholesterolaemia

Journal of Internal Medicine

Volumn 246, Issue 1, 1999, Pages 75-80

  Raal, F J ^a,b   Panz, V R ^a   Pilcher, G J ^a   Joffe, B I ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Atherosclerosis; Familial hypercholesterolaemia; Insulin; Insulin resistance; Leptin

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL;

EID: 0032786508     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00508.x     Document Type: Article

References (39)

1. Reaven GM. Banling Lecture: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Stout RW. Overview of the association between insulin and atherosclerosis. Metabolism 1985: 23 (Suppl.): 7-12.
3. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care 1979; 2: 154-60.
4. Fontbonne A, Charles MD, Thibult N et al. Hyperinsulinaemia as a predictor of coronary artery disease mortality in a healthy population: the Paris Prnspective Study, 15 year follow-up Diabetologia 1991; 34: 356-61.
5. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 134-41.
6. Bressler P, Bailey SR, Matsuda M. Insulin resistance and coronary artery disease. Diabetologia 1996; 39: 1345-50.
7. Shinozaki K, Suzuki M, Ikebuchi M, Hara Y, Harano Y. Demonstration of insulin resistance in coronary heart disease documented with angiography. Diabetes Care 1996; 19: 1-7.
8. Seibaek M, Sloth C, Vallebo L, Hansen T, Urhammer SA, Burchardt H et al. Glucose tolerance status and severity of coronary artery disease in men referred for coronary angiography Am Heart J 1997; 133: 622-9.
9. Howard PHG, O'Leary DH, Zaccaro D et al. Insulin sensitivity and atherosclerosis Circulation 1996; 93: 1809-17.
10. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 1996; 334: 292-5.
11. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-91.
12. Zimmet P, Hodge A, Nicolson M et al. Serum leptin concentration, obesity and insulin resistance in Western Samoans, BMJ 1996: 313: 965-9.
13. Zheng D, Jones JP, Usala SJ, Dohm GL, Differential expression of ob mRNA in rat adipose tissues in response to insulin. Biochem Biophys Res Commun 1996; 218: 434-7.
14. Kolaczynski JW, Nyce MR, Considine RV et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45: 699-701.
15. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Seriver GR, Beaudel AC, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Diseaae, 7th edn. New York. NY, McGraw-Hill, 1995; pp. 1981-2030.
16. Kotze MJ, Langenhoven E, Warnick L. The molecullar basis and diagnosis of familial hypercholesterolemia in South African Afrikaners. Ann Hum Genet 1991; 55: 115-21.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
18. DeFronzo RA, Tobin JD, Andres R. Glocuse clamp techniques: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Homeostasis model asessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
20. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-65.
21. Despres J-P, Lamarche B, Mauriege P etal. Hyperinsulinemia as an independent risk factor for ischaemic heart disease. N Engl J Med 1996; 334: 952-7.
22. Laakso M, Sarlund H, Salonen R et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991; 11: 1068-76.
23. Agewall S, Fagerberg B, Attval S, Wendalhag I, Urbanavicius V, Wikstrand A. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk, Stroke 1995; 26: 956-60.
24. Wingard DL, Ferrara A, Barrett-Connor EL. Is insulin really a heart disease risk factor? Diabetes Care 1995; 18: 1299-304.
25. Taskinen M-R. Strategies for the diagnosis of metabolic syndrome, Curr Opin Lipidol 1993; 4: 434-43.
26. DeFronzo RA, Ferrannini E. Insulin resistance: a multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic vascular disease. Diabetes Care 1991; 14: 173-94.
27. Paolisso G, Ferrannini E, Sgambato S, Varricchio M, D'Onofrio F, Hyperinsulinemia in patients with hypercholesterolaemia. J Clin Endocrinol Metab 1992: 75: 1409-12.
28. Galvan AQ, Santoro D, Natali A et al. Insulin sensitivity in familial hypercholesterolemia. Metab Clin Exp 1993; 42: 1359-64.
29. Karhapää P, Vontilainen E, Kovanen PT, Laakso M. Insulin resistance in familial and nonfamilial hypercholesterolemia. Arterioscler Thromb 1993; 13: 41-7.
30. Paolisso G, Ferrannini E, D'Amore A, Volpe C, Varrichio M, D'Onofrio F. Effects of physiological plasma insulin levels on glucose turnover parameters in familial hypercholesterolaemia. Atherosclerosis 1993; 101: 111-5.
31. Sheu WH, Shieh SM, Fuh MM et al. Insulin resistance, glucose intolerance, and hyperinsulinemia: Hypertriglyceridemia versus hyper-cholesterolemia. Arterioscler Thromb 1993; 13: 367-70.
32. Garg A, Helderman JH, Kaffler M, Ayuso R, Rosenstock J, Roslin P. Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 1988; 37: 982-7.
33. Godsland IF, Stevenson JC. Insulin resistance: syndrome or tendency? Lancet 1995; 546: 100-3.
34. Weintraub MS, Elsenherg S, Breslow JL. Different patterns of postprandial limpoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. J Clin Invest 1987; 79: 1110-9.
35. Tilly-Kiesi MK, Tikkanen MJ. Differential low density lipoprotein hydrated density distribution in female and male patients with familial hypercholesterolaemia. Clinica Chimica Acta 1991; 201: 65-74.
36. Zouvanis M, Raal FJ, Joffe BI, Seftel HC, Microalbuminuria is not associated with cardiovascular disease in patients with homozygous familial hypercholesterolaemia. Atherosclerosis 1995; 113: 289-92.
37. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007-12.
38. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
39. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW et al. The West Of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.